Auriculotherapy for stress and anxiety treatment

Not Applicable

• Conditions: Anxiety; F01.470.132

• Registration Number: RBR-8j8v74
• Lead Sponsor: Instituto Terapia Integrada e Oriental

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-08-19
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Volunteers with a score on the List of Stress Symptoms of 40 to 120 points corresponding to medium and high stress; Age between 18 and 60 years.

Exclusion Criteria

Volunteers who carry out treatment with some complementary practice simultaneously to the data collection; who use controlled-use medications, such as anxiolytics, antidepressants and herbal medicines.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expected reduction of 25% of stress levels according to the List of Stress Symptoms after 6 treatment sessions for the group of auriculotherapy with silicon tablets.<br><br>;Reduction of less than 25% of stress levels according to the List of Stress Symptoms after 6 treatment sessions for the placebo group.;No reduction expected for the Control Group without intervention according to the List of Symptoms of Stress after 6 weeks.;Reduction of 38% of stress levels according to the Stress Symptoms List after 6 treatment sessions for the auriculotherapy group with silicon tablets.;Reduction of 29% of stress levels according to the List of Stress Symptoms after 6 sessions of treatment for the placebo group. ;Increase of 6% of stress levels for the Control Group without intervention according to the List of Symptoms of Stress after 6 weeks.

Secondary Outcome Measures

Name	Time	Method
Expected reduction of 25% of anxiety levels according to the State Trait Anxiety Inventory after 6 treatment sessions for the group of auriculotherapy with silicon tablets<br>;Reduction of less than 25% of anxiety levels according to the State Trait Anxiety Inventory after 6 treatment sessions for the placebo group.<br>;No expected reduction for the Control Group without intervention according to the State Trait Anxiety Inventory after 6 weeks.;Reduction of 19% of anxiety levels according to the State Trait Anxiety Inventory, after 6 treatment sessions for the auriculotherapy group with silicon tablets.;Reduction of 15% of anxiety levels according to the State Trait Anxiety Inventory, after 6 sessions of treatment for the placebo group.;Reduction reached of 1% of anxiety levels according to the State Trait Anxiety Inventory, for the Control Group without intervention, after 6 weeks.